1. Considered and Approved the Audited Standalone Financial Results of the company for the quarter and financial year ended 31st March, 2025 along with the report of the auditors thereon. 2. ....
Awaiting price reaction for this filing.
Soni Medicare Ltd's board, meeting on May 30, 2025, approved audited standalone financial results for Q4 and FY ended March 31, 2025. Statutory auditor Tambi Ashok & Associates issued an unmodified (clean) opinion with no qualifications. Revenue from operations grew to ₹2,983.82 lakhs in FY25 vs ₹2,725.50 lakhs in FY24 (~9.5% growth), while total income rose to ₹3,118.44 lakhs. However, the company still posted a net loss of about ₹27.60 lakhs for FY25, though this was a sharp improvement from the FY24 loss of ₹168.19 lakhs. EPS stood at -₹0.74 for FY25. The board also appointed M/s J S K & Co as Internal Auditor for FY26 and re-appointed M/s Mahendra Khandelwal & Co as Secretarial Auditor for five years.
Revenue growth and a much smaller loss are positives, but the company continues to report losses and its reserves have turned negative (Other Equity at -₹296.65 lakhs), signalling weak balance-sheet health that shareholders should watch closely.